Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Clinical trial NCT03951597 · UNKNOWN
Trial details
- NCT number
- NCT03951597
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-10
- Primary completion
- 2020-01-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.